Cargando…
Genetic polymorphisms of ATG5 predict survival and recurrence in patients with early-stage esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is a deadly disease with high risk of tumor recurrence even among patients with an early pathologic stage of tumor. In the current study, we investigate the association between 20 SNPs of the ATG5 gene and prognosis of patients with early-stage ESCC. A total...
Autores principales: | Yang, Pei-Wen, Hsieh, Min-Shu, Chang, Ya-Han, Huang, Pei-Ming, Lee, Jang-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710940/ https://www.ncbi.nlm.nih.gov/pubmed/29207660 http://dx.doi.org/10.18632/oncotarget.20793 |
Ejemplares similares
-
The genetic effect and molecular function of the SOCS5 in the prognosis of esophageal squamous cell carcinoma
por: Yang, Pei-Wen, et al.
Publicado: (2021) -
Genetic Variants of EGF and VEGF Predict Prognosis of Patients with Advanced Esophageal Squamous Cell Carcinoma
por: Yang, Pei-Wen, et al.
Publicado: (2014) -
Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
por: Yang, Pei-Wen, et al.
Publicado: (2019) -
The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma
por: Hsieh, Min-Shu, et al.
Publicado: (2016) -
Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols
por: Li, Chia-Ying, et al.
Publicado: (2016)